Kaalev Laboratories, Inc., makes generic drugs, which are provided by pharmacies to Medicaid patients. In the state of Nextlandia, a claim is submitted for the cost of the drug to Nextlandia's Medicaid. The claim is paid according to a percentage of the drug's mean wholesale price (WP). Like other drug makers, Kaalev published its products' price. But for more than a dozen years, Kaalev set each amount to meet the requirements to obtain a generic designation for the drug, without regard to the actual price. When Nextlandia Medicaid learned that the actual prices were much lower than the published WP, the state filed a lawsuit in a Nextlandia state court against Kaalev, alleging fraud. Kaalev argued that "WP" was a term of art in the pharmaceutical industry that meant "suggested price." Would a court had accept this argument ? Or would a court deem this behavior unethical